Feedback
Settings

Settings

Goto Application

4,876,247 results
Offices all Languages en Stemming true Single Family Member false Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

DS:GM

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1 / 487,625
1.WO/2002/089216METHOD FOR INCREASING THE OUTPUT POWER OF PHOTOVOLTAIC CELLS
WO - 07.11.2002
Int.Class F24S 23/30
FMECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
24HEATING; RANGES; VENTILATING
SSOLAR HEAT COLLECTORS; SOLAR HEAT SYSTEMS
23Arrangements for concentrating solar rays for solar heat collectors
30with lenses
 Appl.No PCT/DZ2001/000004 Applicant HIHI, Bachir Inventor HIHI, Bachir
The invention concerns a method for increasing the output power of any photovoltaic cell using a linear concentration by means of a mutliprism and for using a special transparent film which can absorb up to 93 % of ultraviolet rays so that the temperature at the surface of the photovoltaic cells is acceptable.
2.WO/2003/048186SURFACE SIMULATION SYNTHETIC PEPTIDES USEFUL IN THE TREATMENT OF HYPER-VARIABLE VIRAL PATHOGENS
WO - 12.06.2003
Int.Class C07K 14/16
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
005from viruses
08RNA viruses
15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
155Lentiviridae, e.g. human immunodeficiency virus , visna-maedi virus or equine infectious anaemia virus
16HIV-1
 Appl.No PCT/US2002/037664 Applicant CREVECOEUR, Harry Inventor CREVECOEUR, Harry
Synthetic peptides and methods for configuring the amino acid sequences thereof are disclosed which are especially useful in the preparation of vaccines intended for the prophylaxis and treatment of viral pathogens exhibiting high mutation rates such as HIV-1. The high mutation rates of such viral pathogens result in extreme variance in the linear sequence of viral protein residues, such as the variable linear sequences of gp 120 of HIV-1. To be effective and provide broad-spectrum and/or cross-clad coverage against hypervariable viruses such as HIV-1, vaccines must target common denominators of all infective strains of such a virus. These functional common denominators lie in the 3-dimensional configuration of proteins essential for host cell binding and infectivity. The disclosed peptides and methods for configuring same are derived from the 3 dimensional relationships of conserved residues of viral proteins defining conformational epitopes necessary and required for viral pathogenicity.
3.WO/2002/080938USE OF SODIUM NUCLEOSPERMATE FOR TREATING AIDS AND TREATMENT METHOD
WO - 17.10.2002
Int.Class A61K 31/7105
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7088Compounds having three or more nucleosides or nucleotides
7105Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
 Appl.No PCT/RU2002/000161 Applicant ASAFOV, Aleksandr Vilenovich Inventor ASAFOV, Aleksandr Vilenovich
The invention relates to medicine and can be used in order to develop medicinal agents (preparations) and treat AIDS. The aim of the invention is to improve the efficiency of the AIDS treatment by using the known sodium nucleospermate as a therapeutic agent, reducing toxicity of said therapeutic agent and extending the list of curing preparations used for treating AIDS, bearing in mind the combined use thereof. The inventive method consists in using the sodium nucleospermate as curing agent against AIDS or as an active principal of the therapeutic agent used for treating AIDS. Said sodium nucleospermate is also used for the inventive treatment method.
4.WO/1998/038164SELECTIVE EPOXIDATION PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS
WO - 03.09.1998
Int.Class C07D 303/38
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
303Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
02Compounds containing oxirane rings
38with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
 Appl.No PCT/US1998/003667 Applicant ELI LILLY AND COMPANY Inventor HOARD, David, W.
Cryptophycin compounds possessing a β-epoxy moiety may be made with high stereoselectivity at various steps in the overall synthetic process. This invention also provides novel intermediates useful in preparing Cryptophycin compounds.
5.WO/1998/038158PROCESS FOR PREPARING PHARMACEUTICAL COMPOUNDS
WO - 03.09.1998
Int.Class C07D 303/38
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
303Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
02Compounds containing oxirane rings
38with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
 Appl.No PCT/US1998/003655 Applicant ELI LILLY AND COMPANY Inventor HOARD, David, W.
Cryptophycin compounds may be prepared utilizing an epoxidation step early in the synthetic process under the conditions set forth herein. This invention also relates to novel intermediates generated by this early epoxidation process.
6.WO/2000/049531APPARATUS AND METHOD FOR DEPERSONALIZING INFORMATION
WO - 24.08.2000
Int.Class G06F 13/00
GPHYSICS
06COMPUTING; CALCULATING OR COUNTING
FELECTRIC DIGITAL DATA PROCESSING
13Interconnection of, or transfer of information or other signals between, memories, input/output devices or central processing units
 Appl.No PCT/US2000/002467 Applicant SMITHKLINE BEECHAM CORPORATION Inventor KOHAN, Mark
A computer implemented method allows an owner or provider of data that contains personal identifiers (data provider) to distribute that data to a data user (118) in a depersonalized form (120) i.e., without revealing the identiTy of the individuals associated with the data (113). The data provider (112) first separates the personal information from the other data to create two data sets (113). The personal identifying information is then provided to a Trusted Third Party (TTP) (116). The TTP associates a unique identifier with the identifying information. The TTP may also collect and store the personal identifying information so that it can process identifying information that it acquires in the future to determine if the unique identifiers generated by the data provider or by the TTP refer to the same individual.
7.WO/1998/056968A NON-WOVEN FABRIC
WO - 17.12.1998
Int.Class B32B 5/02
BPERFORMING OPERATIONS; TRANSPORTING
32LAYERED PRODUCTS
BLAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
5Layered products characterised by the non-homogeneity or physical structure of a layer
02characterised by structural features of a layer comprising fibres or filaments
 Appl.No PCT/GB1998/001571 Applicant WOOL DEVELOPMENT INTERNATIONAL LIMITED Inventor RUSSELL, Stephen
The invention relates to a non-woven fabric comprising a substantial proportion of wool fibres, particularly fibres having an average fibre diameter in the range 15 to 40 microns and a length in the range 12mm to 150mm, such as wool fibres in the nature of 'wool broken top' type fibres, without an additional support substrate such as a base web or net. Fabric products incorporating such a non-woven fabric are described.
8.WO/1998/048822IMPROVED METHODS FOR PROCESSING ACTIVATED PROTEIN C
WO - 05.11.1998
Int.Class A61K 38/48
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
48acting on peptide bonds (3.4)
 Appl.No PCT/US1998/008384 Applicant ELI LILLY AND COMPANY Inventor BAKER, Jeffrey, Clayton
The present invention is broadly directed to a method for reducing autodegradation of activated protein C during processing and purification. The present invention provides aqueous activated protein C solutions and an improved method of processing of such solutions, comprising conducting such processing at an ionic strength of greater than 150 mM and at pH of about 5.5 to less than 6.3.
9.WO/1999/000360PROCESS FOR PREPARING 4-SUBSTITUTED-1H-INDOLE-3-GLYOXAMIDES
WO - 07.01.1999
Int.Class C07D 209/08
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
209Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
02condensed with one carbocyclic ring
04Indoles; Hydrogenated indoles
08with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
 Appl.No PCT/US1998/012173 Applicant ELI LILLY AND COMPANY Inventor KHAU, Vien, Van
A process for preparing 1H-indole-3-glyoxamides useful for inhibiting SPLA2 and novel intermediates useful in the preparation of such compounds.
10.WO/1998/046570SUBSTITUTED HETEROAROMATIC 5-HT1F AGONISTS
WO - 22.10.1998
Int.Class C07D 455/03
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
455Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo quinolizines, e.g. berberine
03containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo quinolizines, e.g. berberine
 Appl.No PCT/US1998/007744 Applicant ELI LILLY AND COMPANY Inventor FILLA, Sandra, Ann
This invention provides novel 5-HT1F agonists of Formula (I) in which X, Y, E, R, A, B, and n are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
# -